Gandhar Oil Q2 FY27 Results: Key Dates for Investors

Results Calendar Takes Shape

Gandhar Oil Refinery (India) Ltd has set out its schedule for the September 2026 quarter results. The company informed exchanges under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations that it will hold an earnings call with analysts and investors on October 28, 2026, at 11:00 a.m. IST. The call is intended to discuss unaudited standalone and consolidated results for the quarter ended September 30, 2026. The period is the second quarter of FY27 and also completes the first half of the financial year.

Board Meeting Set for October 27

A board meeting is scheduled for October 27, 2026, according to the company’s October 19 disclosure. The board will consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. This meeting is the formal corporate action preceding the investor interaction. The earnings call is scheduled for the following day, allowing management to discuss the reported numbers after the board process.

Investor Call Planned for October 28

The October 28 call is relevant for shareholders tracking management commentary on demand, margins, volumes and business conditions. Gandhar Oil’s notice identifies analysts and investors as the participants in the call. The disclosed timing is 11:00 a.m. IST. No financial estimates or guidance for Q2 FY27 were included in the supplied company announcement, so the reported figures will be the key reference point once released.

Q1 FY27 Provides the Latest Reported Reference

The supplied earnings data lists July 22, 2026, as the last earnings date for Q1 FY26-27. Revenue for that quarter was reported at Rs 1,731 crore, with quarter-on-quarter growth of 58.40% and year-on-year growth of 91.81%. Gross profit was Rs 273 crore, while net profit was Rs 205 crore. The same data set showed gross profit growth of 389.32% quarter-on-quarter and net profit growth of 455.74% quarter-on-quarter.

These figures provide the most recent reported financial reference ahead of the September-quarter announcement. However, they do not indicate the Q2 FY27 outcome. Investors will compare the upcoming disclosures with this Q1 FY27 base, alongside the company’s year-earlier September-quarter performance. A supplied results preview cited a September 2025 revenue base of Rs 1,060 crore and profit of Rs 40 crore, but did not provide any Q2 FY27 forecast.

Previous Q2 Performance Showed Sequential Improvement

Gandhar Oil’s Q2 FY26 consolidated revenue was Rs 1,059.9 crore, compared with Rs 903 crore in Q1 FY26. Consolidated EBITDA rose to Rs 65.8 crore from Rs 46 crore over the same sequential comparison. One results summary reported consolidated profit after tax of Rs 39.8 crore in Q2 FY26, against Rs 26.1 crore in Q1 FY26. Another supplied summary reported net profit of Rs 36.06 crore, highlighting a difference between the available result summaries.

The company also reported a consolidated manufacturing gross margin spread of Rs 8,662 per KL for Q2 FY26. For the first half of FY26, consolidated manufacturing volumes were reported at 261,524 KL, a 9% year-on-year increase. The company attributed growth at that time to domestic demand, including demand from pharmaceutical and personal care segments. These historical disclosures offer context but should not be treated as a projection for FY27.

Key Financial Figures

Annual Financial Context

The supplied annual-results table shows revenue of Rs 3,444 crore for March 2026, compared with Rs 3,175.11 crore for March 2025. EBITDA was Rs 229.11 crore in March 2026, versus Rs 160.39 crore a year earlier. Net profit was Rs 138.39 crore, compared with Rs 75.30 crore in March 2025. The table also lists revenue of Rs 2,858.92 crore for March 2024.

The annual numbers show that revenue and profit recovered in the latest reported financial year within the supplied data. At the same time, EBITDA in March 2026 remained below Rs 293.57 crore reported for March 2022. This makes quarterly margin and profitability disclosures important elements of the upcoming result release.

Market Relevance of the Disclosure

For investors, the October schedule establishes when audited-status quarterly information and management discussion will become available. The board meeting will address both standalone and consolidated accounts, which can be relevant where investors compare the company-level and group-level performance. The earnings call may also provide context on volume trends and domestic end-market demand, areas cited in the company’s earlier Q2 FY26 commentary.

The announced events do not include a share-price target, business forecast or dividend decision. Nor do the supplied disclosures state whether the company will issue guidance. As a result, the focus remains on the reported revenue, profit, EBITDA, margins and half-year operating metrics when the board-approved results are released.

What to Watch in the Q2 FY27 Release

Investors can track the relationship between Q2 revenue and the Rs 1,731 crore reported for Q1 FY27. Profitability will also be closely measured against the Rs 205 crore Q1 FY27 net profit figure supplied in the latest earnings data. Any management explanation of manufacturing volumes, gross margin spread and demand across pharmaceutical and personal care applications would add operating context to the financial statements.

The company’s formal next step is the October 27 board meeting for approval of the unaudited Q2 and H1 FY27 results. The analyst and investor call will follow on October 28 at 11:00 a.m. IST. Until those events take place, the available information confirms the timetable but not the September-quarter financial outcome.